Volume 14 Supplement 3

Abstracts from the 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)

Open Access

Rapid speciation of mycobacteria with simultaneous detection of MDR tB

  • Barnali Kakati1Email author,
  • Rajiv Kumar Agarwal1,
  • Biswaroop Chatterjee1,
  • Aarti Kotwal1,
  • Pronoti Sarkar1,
  • Sudhir Singh1,
  • Victor Masih1 and
  • Moirangthem Ajit Singh1
BMC Infectious Diseases201414(Suppl 3):P43

https://doi.org/10.1186/1471-2334-14-S3-P43

Published: 27 May 2014

Background

Multidrug resistance (MDR) TB is on the rise globally and is associated with significant morbidity and mortality. Conventional culture based drug susceptibility testing (DST) for TB drugs is time consuming, leading to diagnostic delays contributing to higher TB morbidity and mortality and exacerbation of ongoing transmission. Moreover most of the NTM(Non tuberculous mycobacteria) that are resistant to common anti tB drugs, can be falsely labeled as MDR tB if not identified correctly. This study was aimed to identify Mycobacterium species and to determine the prevalence of multidrug resistant tuberculosis (MDR tB) by line probe assay.

Methods

This study was done on 76 clinical isolates collected from TB patients who were on Anti tuberculous drug treatment since last six months but without any clinical improvement. Line probe assay was performed for detection, identification of species and drug susceptibility status.

Results

Line probe assay detected 49 isolates (96%) of M. tuberculosis, 1 isolate (1.96%) of M. avium and M. intracellulare each. Out of 49 isolates of M.tuberculosis 9(18.4%) were Rifampicin resistant and 11(22.4%) INH resistant but what was alarming was that 9 isolates (18.4%) were MDR.

Conclusion

The majority of multidrug resistant TB cases are due to ongoing transmission of multidrug resistant strains. This is most likely the result of diagnostic delay, thereby emphasizing the need for rapid diagnostics and line probe assay can be used for the rapid identification of Mycobacterium species and the determination of susceptibility to drugs, which may accelerate the time to effective MDR tB treatment.

Authors’ Affiliations

(1)
Department of Microbiology, Himalayan Institute of Medical Sciences

Copyright

© Kakati et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement